These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


594 related items for PubMed ID: 26603174

  • 1. Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial.
    Grigg MJ, William T, Menon J, Dhanaraj P, Barber BE, Wilkes CS, von Seidlein L, Rajahram GS, Pasay C, McCarthy JS, Price RN, Anstey NM, Yeo TW.
    Lancet Infect Dis; 2016 Feb; 16(2):180-188. PubMed ID: 26603174
    [Abstract] [Full Text] [Related]

  • 2. A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial).
    Grigg MJ, William T, Dhanaraj P, Menon J, Barber BE, von Seidlein L, Rajahram G, Price RN, Anstey NM, Yeo TW.
    BMJ Open; 2014 Aug 19; 4(8):e006005. PubMed ID: 25138814
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial.
    Grigg MJ, William T, Menon J, Barber BE, Wilkes CS, Rajahram GS, Edstein MD, Auburn S, Price RN, Yeo TW, Anstey NM.
    Clin Infect Dis; 2016 Jun 01; 62(11):1403-1411. PubMed ID: 27107287
    [Abstract] [Full Text] [Related]

  • 4. Artemether-Lumefantrine Versus Chloroquine for the Treatment of Uncomplicated Plasmodium knowlesi Malaria: An Open-Label Randomized Controlled Trial CAN KNOW.
    Grigg MJ, William T, Barber BE, Rajahram GS, Menon J, Schimann E, Wilkes CS, Patel K, Chandna A, Price RN, Yeo TW, Anstey NM.
    Clin Infect Dis; 2018 Jan 06; 66(2):229-236. PubMed ID: 29020373
    [Abstract] [Full Text] [Related]

  • 5. The Treatment of Plasmodium knowlesi Malaria.
    Barber BE, Grigg MJ, William T, Yeo TW, Anstey NM.
    Trends Parasitol; 2017 Mar 06; 33(3):242-253. PubMed ID: 27707609
    [Abstract] [Full Text] [Related]

  • 6. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M, Khanthavong M, Lindegårdh N, Keola S, Barends M, Pongvongsa T, Yapom R, Annerberg A, Phompida S, Phetsouvanh R, White NJ, Newton PN.
    Clin Infect Dis; 2004 Oct 15; 39(8):1139-47. PubMed ID: 15486837
    [Abstract] [Full Text] [Related]

  • 7. Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.
    Rueangweerayut R, Phyo AP, Uthaisin C, Poravuth Y, Binh TQ, Tinto H, Pénali LK, Valecha N, Tien NT, Abdulla S, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, Pyronaridine–Artesunate Study Team.
    N Engl J Med; 2012 Apr 05; 366(14):1298-309. PubMed ID: 22475593
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F, Kyaw MK, Phe O, Aye KZ, Htet L, Barends M, Lindegardh N, Singtoroj T, Ashley E, Lwin S, Stepniewska K, White NJ.
    Lancet; 2006 Jun 24; 367(9528):2075-85. PubMed ID: 16798391
    [Abstract] [Full Text] [Related]

  • 9. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.
    Held J, Supan C, Salazar CL, Tinto H, Bonkian LN, Nahum A, Moulero B, Sié A, Coulibaly B, Sirima SB, Siribie M, Otsyula N, Otieno L, Abdallah AM, Kimutai R, Bouyou-Akotet M, Kombila M, Koiwai K, Cantalloube C, Din-Bell C, Djeriou E, Waitumbi J, Mordmüller B, Ter-Minassian D, Lell B, Kremsner PG.
    Lancet Infect Dis; 2015 Dec 24; 15(12):1409-19. PubMed ID: 26342427
    [Abstract] [Full Text] [Related]

  • 10. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
    Valecha N, Phyo AP, Mayxay M, Newton PN, Krudsood S, Keomany S, Khanthavong M, Pongvongsa T, Ruangveerayuth R, Uthaisil C, Ubben D, Duparc S, Bacchieri A, Corsi M, Rao BH, Bhattacharya PC, Dubhashi N, Ghosh SK, Dev V, Kumar A, Pukrittayakamee S.
    PLoS One; 2010 Jul 30; 5(7):e11880. PubMed ID: 20689583
    [Abstract] [Full Text] [Related]

  • 11. Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia.
    William T, Menon J, Rajahram G, Chan L, Ma G, Donaldson S, Khoo S, Frederick C, Jelip J, Anstey NM, Yeo TW.
    Emerg Infect Dis; 2011 Jul 30; 17(7):1248-55. PubMed ID: 21762579
    [Abstract] [Full Text] [Related]

  • 12. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
    Smithuis F, Shahmanesh M, Kyaw MK, Savran O, Lwin S, White NJ.
    Trop Med Int Health; 2004 Nov 30; 9(11):1184-90. PubMed ID: 15548314
    [Abstract] [Full Text] [Related]

  • 13. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
    Barber BE, William T, Grigg MJ, Menon J, Auburn S, Marfurt J, Anstey NM, Yeo TW.
    Clin Infect Dis; 2013 Feb 30; 56(3):383-97. PubMed ID: 23087389
    [Abstract] [Full Text] [Related]

  • 14. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
    Rogers WO, Sem R, Tero T, Chim P, Lim P, Muth S, Socheat D, Ariey F, Wongsrichanalai C.
    Malar J; 2009 Jan 12; 8():10. PubMed ID: 19138388
    [Abstract] [Full Text] [Related]

  • 15. Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infections.
    Daneshvar C, Davis TM, Cox-Singh J, Rafa'ee MZ, Zakaria SK, Divis PC, Singh B.
    Malar J; 2010 Aug 19; 9():238. PubMed ID: 20723228
    [Abstract] [Full Text] [Related]

  • 16. Artemisinin-based combination therapy for knowlesi malaria.
    Ramharter M.
    Lancet Infect Dis; 2016 Feb 19; 16(2):134-6. PubMed ID: 26603170
    [No Abstract] [Full Text] [Related]

  • 17. A comparative clinical trial of sequential treatments of severe malaria with artesunate suppository followed by mefloquine in Thailand.
    Looareesuwan S, Wilairatana P, Molunto W, Chalermrut K, Olliaro P, Andrial M.
    Am J Trop Med Hyg; 1997 Sep 19; 57(3):348-53. PubMed ID: 9311648
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
    Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS, Bustos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, Pyronaridine-artesunate Study Team.
    Lancet; 2010 Apr 24; 375(9724):1457-67. PubMed ID: 20417857
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.
    Sagara I, Beavogui AH, Zongo I, Soulama I, Borghini-Fuhrer I, Fofana B, Camara D, Somé AF, Coulibaly AS, Traore OB, Dara N, Kabore MJ, Thera I, Compaore YD, Sylla MM, Nikiema F, Diallo MS, Dicko A, Gil JP, Borrmann S, Duparc S, Miller RM, Doumbo OK, Shin J, Bjorkman A, Ouedraogo JB, Sirima SB, Djimdé AA.
    Lancet Infect Dis; 2016 Feb 24; 16(2):189-98. PubMed ID: 26601738
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru.
    Marquiño W, Huilca M, Calampa C, Falconí E, Cabezas C, Naupay R, Ruebush TK.
    Am J Trop Med Hyg; 2003 May 24; 68(5):608-12. PubMed ID: 12812355
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.